752 related articles for article (PubMed ID: 12112774)
21. Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre.
Dijk FN; McKay K; Barzi F; Gaskin KJ; Fitzgerald DA
Arch Dis Child; 2011 Dec; 96(12):1118-23. PubMed ID: 21994242
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening.
Maselli JH; Sontag MK; Norris JM; MacKenzie T; Wagener JS; Accurso FJ
Pediatr Pulmonol; 2003 Apr; 35(4):257-62. PubMed ID: 12629621
[TBL] [Abstract][Full Text] [Related]
23. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection.
Johansen HK; Nørregaard L; Gøtzsche PC; Pressler T; Koch C; Høiby N
Pediatr Pulmonol; 2004 May; 37(5):427-32. PubMed ID: 15095326
[TBL] [Abstract][Full Text] [Related]
24. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
[TBL] [Abstract][Full Text] [Related]
25. Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection.
Donnelly RF; McCarron PA; Cassidy CM; Elborn JS; Tunney MM
J Control Release; 2007 Feb; 117(2):217-26. PubMed ID: 17196290
[TBL] [Abstract][Full Text] [Related]
26. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections.
Roy-Burman A; Savel RH; Racine S; Swanson BL; Revadigar NS; Fujimoto J; Sawa T; Frank DW; Wiener-Kronish JP
J Infect Dis; 2001 Jun; 183(12):1767-74. PubMed ID: 11372029
[TBL] [Abstract][Full Text] [Related]
27. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.
Armstrong DS; Grimwood K; Carlin JB; Carzino R; Olinsky A; Phelan PD
Pediatr Pulmonol; 1996 May; 21(5):267-75. PubMed ID: 8726151
[TBL] [Abstract][Full Text] [Related]
28. Familial concordance of phenotype and microbial variation among siblings with CF.
Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
[TBL] [Abstract][Full Text] [Related]
29. Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis.
Psoter KJ; De Roos AJ; Mayer JD; Kaufman JD; Wakefield J; Rosenfeld M
Ann Am Thorac Soc; 2015 Mar; 12(3):385-91. PubMed ID: 25594356
[TBL] [Abstract][Full Text] [Related]
30. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study.
Slieker MG; van den Berg JM; Kouwenberg J; van Berkhout FT; Heijerman HG; van der Ent CK
Pediatr Pulmonol; 2010 Jun; 45(6):601-7. PubMed ID: 20503286
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcome of cystic fibrosis presenting with or without meconium ileus: a matched cohort study.
Munck A; Gérardin M; Alberti C; Ajzenman C; Lebourgeois M; Aigrain Y; Navarro J
J Pediatr Surg; 2006 Sep; 41(9):1556-60. PubMed ID: 16952591
[TBL] [Abstract][Full Text] [Related]
32. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!
Farrell PM; Lai HJ; Li Z; Kosorok MR; Laxova A; Green CG; Collins J; Hoffman G; Laessig R; Rock MJ; Splaingard ML
J Pediatr; 2005 Sep; 147(3 Suppl):S30-6. PubMed ID: 16202779
[TBL] [Abstract][Full Text] [Related]
33. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.
Hoiby N; Flensborg EW; Beck B; Friis B; Jacobsen SV; Jacobsen L
Scand J Respir Dis; 1977 Apr; 58(2):65-79. PubMed ID: 404701
[TBL] [Abstract][Full Text] [Related]
34. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
Hansen CR; Pressler T; Koch C; Høiby N
J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
[TBL] [Abstract][Full Text] [Related]
35. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].
Coman G; Petraru E; Dahorea C; Anton DT
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957
[TBL] [Abstract][Full Text] [Related]
36. Cost of care and clinical condition in paediatric cystic fibrosis patients.
Baumann U; Stocklossa C; Greiner W; von der Schulenburg JM; von der Hardt H
J Cyst Fibros; 2003 Jun; 2(2):84-90. PubMed ID: 15463855
[TBL] [Abstract][Full Text] [Related]
37. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
Nguyen D; Emond MJ; Mayer-Hamblett N; Saiman L; Marshall BC; Burns JL
Pediatr Pulmonol; 2007 Jun; 42(6):533-41. PubMed ID: 17469154
[TBL] [Abstract][Full Text] [Related]
38. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis.
da Silva Filho LV; Tateno AF; Martins KM; Azzuz Chernishev AC; Garcia Dde O; Haug M; Meisner C; Rodrigues JC; Döring G
Pediatr Pulmonol; 2007 Oct; 42(10):938-44. PubMed ID: 17722007
[TBL] [Abstract][Full Text] [Related]
39. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
[TBL] [Abstract][Full Text] [Related]
40. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
Etherington C; Hall M; Conway S; Peckham D; Denton M
J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
